OOIR: Observatory of International Research

Papers

(The H4-Index of JACC: Cardiooncology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Editorial Board	140
Full Issue PDF	133
Full Issue PDF	117
Full Issue PDF	110
LAG3 Blockade Expands T Cells Within Atherosclerotic Plaque	108
Priorities in Cardio-Oncology	95
Cardiovascular Safety in Oncology Clinical Trials	90
Hormonal Therapy and Cardiovascular Health	77
Prospective Screening for Transthyretin Cardiac Amyloidosis in Spinal Stenosis Surgery Patients	69
Full Issue PDF	63
To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy	60
Atrial Fibrillation in Patients With Cancer	58
Epigenomics of Cardio-Oncology	57
Balancing Promise and Evidence	56
Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy	56
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part	55
SGLT2i and Primary Prevention of Cancer Therapy–Related Cardiac Dysfunction in Patients With Diabetes	53
Full Issue PDF	52
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies	52
Assessing Neurohormonal Antagonist Withdrawal in HER2+ Breast Cancer Patients With CTRCD	50
Novel Technologies Must Be Considered for Childhood Cancer Survivors at Risk for Cardiomyopathy	49
Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors	48
Cardiac Risk Stratification Before Lung Cancer Radiation	46
Rivaroxaban Efficacy and Safety in SELECT-D Community Cancer-Associated Venous Thromboembolism Patients	46
CARDIAC, MUSCULAR, AND NEUROLOGICAL TOXICITY SECONDARY TO PEMBROLIZUMAB IN A PATIENT WITH MELANOMA	43

Long-Term, Implantable Event Monitoring of Patients With Wild-Type Transthyretin Cardiac Amyloidosis	43
Frailty	42
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms	39
Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma	38
Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis	38
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy	37
Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213)	37
PROPORTIONATE AND ABSOLUTE PULMONARY EMBOLISM MORTALITY IN ONCOLOGY IN THE UNITED STATES FROM 1999-2019	35
Editorial Board/Officers Page	34
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients	34